ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 19 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $47,636 | -55.8% | 65,714 | -67.8% | 0.04% | -56.8% |
| Q4 2022 | $107,799 | -68.6% | 203,971 | -50.5% | 0.10% | -78.1% |
| Q3 2022 | $343,000 | -40.0% | 411,896 | -21.5% | 0.43% | +11.3% |
| Q2 2022 | $572,000 | +26.3% | 524,805 | +44.9% | 0.39% | +472.1% |
| Q1 2022 | $453,000 | -93.1% | 362,072 | -65.4% | 0.07% | -92.7% |
| Q2 2021 | $6,611,000 | +1193.7% | 1,045,987 | +331.8% | 0.93% | +841.4% |
| Q1 2021 | $511,000 | -0.4% | 242,237 | -51.8% | 0.10% | -12.4% |
| Q4 2018 | $513,000 | -37.0% | 502,448 | +8.0% | 0.11% | +8.7% |
| Q3 2018 | $814,000 | +8.5% | 465,039 | +36.5% | 0.10% | -10.3% |
| Q2 2018 | $750,000 | – | 340,749 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QCM Cayman, Ltd. | 22,301 | $36,000 | 0.22% |
| XTX Topco Ltd | 17,275 | $28,000 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 2,371,193 | $3,794,000 | 0.01% |
| TWO SIGMA ADVISERS, LP | 1,597,930 | $2,557,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 4,147,809 | $6,637,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 129,916 | $208,000 | 0.01% |
| Graham Capital Management, L.P. | 73,105 | $116,000 | 0.01% |
| Caption Management, LLC | 300,000 | $480,000 | 0.01% |
| Engineers Gate Manager LP | 60,809 | $97,000 | 0.00% |
| Castleview Partners, LLC | 800 | $500,000 | 0.00% |